vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Nine Energy Service, Inc. (NINE). Click either name above to swap in a different company.

Nine Energy Service, Inc. is the larger business by last-quarter revenue ($132.2M vs $75.1M, roughly 1.8× MEDIFAST INC). On growth, Nine Energy Service, Inc. posted the faster year-over-year revenue change (-6.5% vs -36.9%). Nine Energy Service, Inc. produced more free cash flow last quarter ($-4.8M vs $-6.6M). Over the past eight quarters, Nine Energy Service, Inc.'s revenue compounded faster (-3.6% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Xcel Energy Inc. is a U.S. regulated electric utility and natural gas delivery company based in Minneapolis, Minnesota, serving approximately 3.9 million electricity customers and 2.2 million natural gas customers across parts of eight states as of mid-2025. It consists of four operating subsidiaries: Northern States Power-Minnesota, Northern States Power-Wisconsin, Public Service Company of Colorado, and Southwestern Public Service Co.

MED vs NINE — Head-to-Head

Bigger by revenue
NINE
NINE
1.8× larger
NINE
$132.2M
$75.1M
MED
Growing faster (revenue YoY)
NINE
NINE
+30.3% gap
NINE
-6.5%
-36.9%
MED
More free cash flow
NINE
NINE
$1.8M more FCF
NINE
$-4.8M
$-6.6M
MED
Faster 2-yr revenue CAGR
NINE
NINE
Annualised
NINE
-3.6%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
NINE
NINE
Revenue
$75.1M
$132.2M
Net Profit
$-19.2M
Gross Margin
69.4%
Operating Margin
-10.4%
-4.2%
Net Margin
-14.5%
Revenue YoY
-36.9%
-6.5%
Net Profit YoY
-117.4%
EPS (diluted)
$-1.64
$-0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
NINE
NINE
Q4 25
$75.1M
$132.2M
Q3 25
$89.4M
$132.0M
Q2 25
$105.6M
$147.3M
Q1 25
$115.7M
$150.5M
Q4 24
$119.0M
$141.4M
Q3 24
$140.2M
$138.2M
Q2 24
$168.6M
$132.4M
Q1 24
$174.7M
$142.1M
Net Profit
MED
MED
NINE
NINE
Q4 25
$-19.2M
Q3 25
$-2.3M
$-14.6M
Q2 25
$2.5M
$-10.4M
Q1 25
$-772.0K
$-7.1M
Q4 24
$-8.8M
Q3 24
$1.1M
$-10.1M
Q2 24
$-8.2M
$-14.0M
Q1 24
$8.3M
$-8.1M
Gross Margin
MED
MED
NINE
NINE
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
NINE
NINE
Q4 25
-10.4%
-4.2%
Q3 25
-4.6%
-0.9%
Q2 25
-1.0%
2.3%
Q1 25
-1.1%
3.7%
Q4 24
0.6%
2.5%
Q3 24
1.5%
1.8%
Q2 24
-4.7%
-1.1%
Q1 24
4.5%
3.1%
Net Margin
MED
MED
NINE
NINE
Q4 25
-14.5%
Q3 25
-2.5%
-11.1%
Q2 25
2.3%
-7.1%
Q1 25
-0.7%
-4.7%
Q4 24
-6.3%
Q3 24
0.8%
-7.3%
Q2 24
-4.8%
-10.6%
Q1 24
4.8%
-5.7%
EPS (diluted)
MED
MED
NINE
NINE
Q4 25
$-1.64
$-0.47
Q3 25
$-0.21
$-0.35
Q2 25
$0.22
$-0.25
Q1 25
$-0.07
$-0.18
Q4 24
$0.08
$-0.21
Q3 24
$0.10
$-0.26
Q2 24
$-0.75
$-0.40
Q1 24
$0.76
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
NINE
NINE
Cash + ST InvestmentsLiquidity on hand
$167.3M
$18.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$-115.0M
Total Assets
$248.0M
$339.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
NINE
NINE
Q4 25
$167.3M
$18.4M
Q3 25
$173.5M
$14.4M
Q2 25
$162.7M
$14.2M
Q1 25
$164.6M
$17.3M
Q4 24
$162.3M
$27.9M
Q3 24
$170.0M
$15.7M
Q2 24
$163.5M
$26.0M
Q1 24
$156.4M
$10.2M
Stockholders' Equity
MED
MED
NINE
NINE
Q4 25
$198.9M
$-115.0M
Q3 25
$214.7M
$-95.9M
Q2 25
$216.0M
$-81.7M
Q1 25
$211.0M
$-72.1M
Q4 24
$210.1M
$-66.1M
Q3 24
$207.3M
$-57.6M
Q2 24
$205.3M
$-49.7M
Q1 24
$211.0M
$-43.3M
Total Assets
MED
MED
NINE
NINE
Q4 25
$248.0M
$339.5M
Q3 25
$268.2M
$340.7M
Q2 25
$269.3M
$361.2M
Q1 25
$280.0M
$359.2M
Q4 24
$284.2M
$360.1M
Q3 24
$291.2M
$353.2M
Q2 24
$293.5M
$381.7M
Q1 24
$302.8M
$380.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
NINE
NINE
Operating Cash FlowLast quarter
$-5.3M
$-2.2M
Free Cash FlowOCF − Capex
$-6.6M
$-4.8M
FCF MarginFCF / Revenue
-8.8%
-3.6%
Capex IntensityCapex / Revenue
1.8%
2.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
NINE
NINE
Q4 25
$-5.3M
$-2.2M
Q3 25
$12.1M
$-9.9M
Q2 25
$-3.4M
$10.1M
Q1 25
$3.4M
$-5.3M
Q4 24
$-4.9M
$15.0M
Q3 24
$9.1M
$-5.8M
Q2 24
$13.1M
$12.9M
Q1 24
$7.3M
$-8.8M
Free Cash Flow
MED
MED
NINE
NINE
Q4 25
$-6.6M
$-4.8M
Q3 25
$10.8M
$-13.4M
Q2 25
$-4.8M
$4.2M
Q1 25
$1.9M
$-9.3M
Q4 24
$-7.2M
$11.8M
Q3 24
$7.7M
$-9.3M
Q2 24
$11.1M
$10.3M
Q1 24
$5.4M
$-14.3M
FCF Margin
MED
MED
NINE
NINE
Q4 25
-8.8%
-3.6%
Q3 25
12.0%
-10.2%
Q2 25
-4.5%
2.9%
Q1 25
1.6%
-6.2%
Q4 24
-6.1%
8.3%
Q3 24
5.5%
-6.7%
Q2 24
6.6%
7.7%
Q1 24
3.1%
-10.1%
Capex Intensity
MED
MED
NINE
NINE
Q4 25
1.8%
2.0%
Q3 25
1.5%
2.6%
Q2 25
1.3%
4.0%
Q1 25
1.3%
2.6%
Q4 24
1.9%
2.3%
Q3 24
1.0%
2.5%
Q2 24
1.1%
2.0%
Q1 24
1.1%
3.9%
Cash Conversion
MED
MED
NINE
NINE
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

NINE
NINE

Cement$52.6M40%
Tool Revenue$28.6M22%
Coiled Tubing$25.8M20%
Wireline$25.1M19%

Related Comparisons